MegaPro and China Chemical & Pharmaceutical Co., Ltd. have conducted strategic cooperation and negotiations to elaborate the applications of technology platforms and enhance the value of products development. CCPC is optimistic about the potential of MegaPro and the growth of the nanomedicine market. Therefore CCPC decided to participate in the D round financing of MegaPro, becoming an important strategic partner.

In addition to investing in the equity shares of Megapro, CCPC has also obtained its nanomicelle technology license to promote future products and accelerate the mass production and marketing of nanomedicines.